We recently published an article titled Why These 15 Large-Cap Stocks Are Plunging So Far In 2025. In this article, we are ...
Stevanato's 2024 revenue hits €1.1B, driven by biopharma growth! Discover how facility expansions & rising demand are transforming their market impact.
Proficio Capital Partners LLC acquired a new stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) in the fourth quarter, ...
21h
Fate Therapeutics (NASDAQ:FATE – Free Report) had its target price trimmed by Wells Fargo & Company from $5.00 to $4.00 in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback